<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK548324" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK548324/" /><meta name="ncbi_pagename" content="Nifedipine - LiverTox - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Nifedipine - LiverTox - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Nifedipine" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2017/01/11" /><meta name="citation_pmid" content="31643646" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK548324/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Nifedipine" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2017/01/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK548324/" /><meta name="description" content="Nifedipine is a first generation calcium channel blocker used to treat hypertension and angina pectoris. Nifedipine therapy is associated with a low rate of serum enzyme elevations and has been linked to several instances of clinically apparent acute liver injury." /><meta name="og:title" content="Nifedipine" /><meta name="og:type" content="book" /><meta name="og:description" content="Nifedipine is a first generation calcium channel blocker used to treat hypertension and angina pectoris. Nifedipine therapy is associated with a low rate of serum enzyme elevations and has been linked to several instances of clinically apparent acute liver injury." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK548324/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/Nifedipine/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK548324/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CF28B0466CA810000000006FB021A.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All Drug Records" href="/books/n/livertox/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" alt="Cover of LiverTox" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK548324_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK548324_dtls__"><div>Bethesda (MD): <a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>; 2012-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/livertox/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Nicotine/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Nilotinib/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK548324_"><span class="title" itemprop="name">Nifedipine</span></h1><p class="small">Last Update: <span itemprop="dateModified">January 11, 2017</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="Nifedipine.OVERVIEW"><h2 id="_Nifedipine_OVERVIEW_">OVERVIEW</h2><div id="Nifedipine.Introduction"><h3>Introduction</h3><p>Nifedipine is a first generation calcium channel blocker used to treat hypertension and angina pectoris. Nifedipine therapy is associated with a low rate of serum enzyme elevations and has been linked to several instances of clinically apparent acute liver injury.</p></div><div id="Nifedipine.Background"><h3>Background</h3><p>Nifedipine (nye fed' i peen) belongs to the dihydropyridine class of calcium channel blockers (first in its class and similar to amlodipine, felodipine and nicardipine) and is used for the treatment of hypertension and angina pectoris. Like other calcium channel blockers, nifedipine acts by inhibiting the transmembrane influx of calcium into cardiac and smooth muscle cells during depolarization. The inhibition of calcium influx causes arterial vasodilation and decreases cardiac work and oxygen consumption. Nifedipine was approved in the United States in 1982 and currently several million prescriptions are filled yearly. Current indications include hypertension and chronic stable and Prinzmetal's variant angina pectoris. It is also used off label to treat Raynaud phenomenon. Nifedipine is available in capsules of 10 and 20 mg and as extended release tablets of 30, 60 and 90 mg in several generic formulations as well as under brand names including Procardia, Adala, Afeditab, Nifediac, and Nifedical. The typical dose in adults is 30 to 60 mg daily, usually starting with lower doses. Nifedipine is generally well tolerated and side effects are largely due to its vasodilating activities and can include dizziness, flushing, headache, fatigue, nausea, diarrhea, palpitations, bradycardia, peripheral edema and skin rash.</p></div><div id="Nifedipine.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>Mild and transient elevations in serum aminotransferase levels may occur during nifedipine therapy, but often resolve even with continuation of therapy. Clinically apparent acute liver injury with jaundice due to nifedipine is rare and described only in isolated case reports. The time to onset of injury is typically 1 to 2 months and the pattern of serum enzyme elevations is usually hepatocellular or mixed. Rash, arthralgias, fever and eosinophilia can occur, but are not prominent. Chronic aminotransferase elevations during continued therapy with nifedipine have been described sometimes with histological features of alcoholic liver disease (steatosis and <a class="def" href="/books/n/livertox/glossary/def-item/glossary.mallory-bodies/">Mallory bodies</a>), but chronic liver injury after withdrawal has not. Nifedipine has not been implicated in cases of vanishing bile duct syndrome or acute liver failure in the published literature.</p><p>Likelihood score: B (likely cause of clinically apparent liver injury).</p></div><div id="Nifedipine.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>The mechanism of nifedipine hepatotoxicity is not known, but is likely to be due to production of a toxic or immunogenic intermediate during its metabolism by the liver.</p></div><div id="Nifedipine.Outcome_and_Management"><h3>Outcome and Management</h3><p>The severity of liver injury from nifedipine ranges from mild and transient serum enzyme elevations to self-limited jaundice to an alcoholic hepatitis-like syndrome. Complete recovery is expected after stopping the drug and recovery is usually rapid (3 to 8 weeks). There is little information on cross sensitivity to liver injury among the various calcium channel blockers, but related medications should be started with caution in patients with clinically apparent liver injury from nifedipine.</p><p>Drug Class: Cardiovascular Agents, <a href="/books/n/livertox/CalciumChannelBlocke/">Calcium Channel Blockers</a></p><p>Other Drugs in the Subclass, Calcium Channel Blockers: <a href="/books/n/livertox/Amlodipine/">Amlodipine</a>, <a href="/books/n/livertox/Diltiazem/">Diltiazem</a>, <a href="/books/n/livertox/Felodipine/">Felodipine</a>, <a href="/books/n/livertox/Isradipine/">Isradipine</a>, <a href="/books/n/livertox/Nicardipine/">Nicardipine</a>, <a href="/books/n/livertox/Nimodipine/">Nimodipine</a>, <a href="/books/n/livertox/Nisoldipine/">Nisoldipine</a>, <a href="/books/n/livertox/Verapamil/">Verapamil</a></p></div></div><div id="Nifedipine.CASE_REPORT"><h2 id="_Nifedipine_CASE_REPORT_">CASE REPORT</h2><div id="Nifedipine.Case_1._Acute_hepatitis-like_"><h3>Case 1. Acute hepatitis-like syndrome attributed to amlopidine.</h3><p>[Modified from: Basile C, Mascia E. Dihydropyridine calcium channel blockers: a rare and reversible cause of hepatotoxicity with cholestasis in a CAPD patient. Nephrol Dial Transplant 1999; 14: 2776-7. <a href="https://www.ncbi.nlm.nih.gov/pubmed/10534534" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>]</p><p>A 76 year old man with diabetes and end stage renal disease developed jaundice while on long term nifedipine therapy (60 mg daily for ~3 years) for hypertension. He was taking insulin, but no other medications. He had no risk factors for viral hepatitis and did not drink alcohol. Serum bilirubin was 2.5 mg/dL and rose over the next few months to 6.2 mg/dL. Tests for acute hepatitis A, B and C were negative and abdominal ultrasonography showed a normal liver and gallbladder. Nifedipine was stopped and he recovered rapidly. Several months later, amlodipine was started (10 mg daily) and within 6 weeks, he developed jaundice and a cholestatic pattern of serum enzyme elevations. Once amlodipine was stopped, liver tests improved and were normal three weeks later.</p><div id="Nifedipine.Key_Points"><h4>Key Points</h4><div id="Nifedipine.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548324/table/Nifedipine.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Nifedipine.T1_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><b>Medication:</b></td><td rowspan="1" colspan="1" style="vertical-align:top;">Nifedipine (60 mg daily) and then amlodipine (10 mg daily)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><b>Pattern:</b></td><td rowspan="1" colspan="1" style="vertical-align:top;">Cholestatic (R=0.3 and 0.8 during recurrence)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><b>Severity:</b></td><td rowspan="1" colspan="1" style="vertical-align:top;">2+ (jaundiced, but not hospitalized for liver injury)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><b><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</b></td><td rowspan="1" colspan="1" style="vertical-align:top;">3 years for nifedipine, 2 months for amlodipine</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><b>Recovery:</b></td><td rowspan="1" colspan="1" style="vertical-align:top;">3 to 4 weeks</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><b>Other medications:</b></td><td rowspan="1" colspan="1" style="vertical-align:top;">Insulin</td></tr></tbody></table></div></div></div><div id="Nifedipine.Laboratory_Values"><h4>Laboratory Values</h4><div id="Nifedipine.T2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548324/table/Nifedipine.T2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Nifedipine.T2_lrgtbl__"><table><thead><tr><th id="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Date</th><th id="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Duration Therapy</th><th id="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Time After Stopping</th><th id="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> (U/L)</th><th id="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Alk P (U/L)</th><th id="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a> (mg/dL)</th><th id="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1 hd_h_Nifedipine.T2_1_1_1_2 hd_h_Nifedipine.T2_1_1_1_3 hd_h_Nifedipine.T2_1_1_1_4 hd_h_Nifedipine.T2_1_1_1_5 hd_h_Nifedipine.T2_1_1_1_6 hd_h_Nifedipine.T2_1_1_1_7" colspan="7" rowspan="1" style="vertical-align:top;">Long term therapy with nifedipine (60 mg daily)</td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">May 12, 1998</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 years</td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">13</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">144</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">0.3</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Sep 9, 1998</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">47</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">783</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">0.5</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Dec 9, 1998</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">40</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">955</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">2.5</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Jan 11, 1999</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3.5 years</td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">79</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">...</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">6.2</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1 hd_h_Nifedipine.T2_1_1_1_2 hd_h_Nifedipine.T2_1_1_1_3 hd_h_Nifedipine.T2_1_1_1_4 hd_h_Nifedipine.T2_1_1_1_5 hd_h_Nifedipine.T2_1_1_1_6 hd_h_Nifedipine.T2_1_1_1_7" colspan="7" rowspan="1" style="vertical-align:top;">Nifepidine stopped January 11, 1999</td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Jan 16, 1999</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">1 week</td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">46</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">531</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">4.0</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Jan 23, 1999</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">2 weeks</td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">45</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">419</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">1.8</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Feb 11, 1999</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">4 weeks</td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">17</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">185</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">0.9</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1 hd_h_Nifedipine.T2_1_1_1_2 hd_h_Nifedipine.T2_1_1_1_3 hd_h_Nifedipine.T2_1_1_1_4 hd_h_Nifedipine.T2_1_1_1_5 hd_h_Nifedipine.T2_1_1_1_6 hd_h_Nifedipine.T2_1_1_1_7" colspan="7" rowspan="1" style="vertical-align:top;">Amlodipine (10 mg daily) started in late March, 1999</td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Apr 10, 1999</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">2 weeks</td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">43</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">398</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">0.6</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">May 5, 1999</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">6 weeks</td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">74</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">398</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">6.3</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1 hd_h_Nifedipine.T2_1_1_1_2 hd_h_Nifedipine.T2_1_1_1_3 hd_h_Nifedipine.T2_1_1_1_4 hd_h_Nifedipine.T2_1_1_1_5 hd_h_Nifedipine.T2_1_1_1_6 hd_h_Nifedipine.T2_1_1_1_7" colspan="7" rowspan="1" style="vertical-align:top;">Amlodipine stopped May 7, 1999</td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">May 11, 1999</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">4 days</td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">70</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">399</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">5.4</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">May 13, 1999</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">6 days</td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">54</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">314</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">4.1</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">May 28, 1999</td><td headers="hd_h_Nifedipine.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Nifedipine.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">3 weeks</td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">19</td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">181</td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">1.3</td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Nifedipine.T2_1_1_1_1 hd_h_Nifedipine.T2_1_1_1_2 hd_h_Nifedipine.T2_1_1_1_3" colspan="3" rowspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_Nifedipine.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;55</b></td><td headers="hd_h_Nifedipine.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;250</b></td><td headers="hd_h_Nifedipine.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;1.2</b></td><td headers="hd_h_Nifedipine.T2_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div></div><div id="Nifedipine.Comment"><h4>Comment</h4><p>One of the few reports of acute liver injury with jaundice attributed to calcium channel blockers. The patient initially developed a cholestatic hepatitis while on long term nifepidine therapy. Liver tests because steadily worse and nifepidine was ultimately withdrawn, whereupon liver tests fell to normal within 4 weeks. There was a recurrence of liver injury within 2 to 6 weeks of restarting another calcium channel blocker, with a similar pattern of liver test abnormalities and a similar rapid improvement upon stopping. Both nifedipine and amlodipine are dihydropyridines, but there structures are dissimilar.</p></div></div></div><div id="Nifedipine.PRODUCT_INFORMATION"><h2 id="_Nifedipine_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><div id="Nifedipine.BPI" class="box"><p><b>REPRESENTATIVE TRADE NAMES</b></p><p>Nifedipine &#x02013; Generic, Adalat&#x000ae;, Procardia&#x000ae;</p><p><b>DRUG CLASS</b></p><p>Cardiovascular Agents</p><p><a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&#x00026;query=nifedipine" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COMPLETE LABELING</a></p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div></div><div id="Nifedipine.CHEMICAL_FORMULA_AND_STRUCTUR"><h2 id="_Nifedipine_CHEMICAL_FORMULA_AND_STRUCTUR_">CHEMICAL FORMULA AND STRUCTURE</h2><div id="Nifedipine.T3" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548324/table/Nifedipine.T3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Nifedipine.T3_lrgtbl__"><table><thead><tr><th id="hd_h_Nifedipine.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_Nifedipine.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NO</th><th id="hd_h_Nifedipine.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Nifedipine.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Nifedipine.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Nifedipine</td><td headers="hd_h_Nifedipine.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/134994994" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">21829-25-4</a></td><td headers="hd_h_Nifedipine.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C17-H18-N2-O6</td><td headers="hd_h_Nifedipine.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548324/bin/Nifedipine_Structure.jpg" alt="Nifedipine chemical structure" /></div></td></tr></tbody></table></div></div></div><div id="Nifedipine.ANNOTATED_BIBLIOGRAPHY"><h2 id="_Nifedipine_ANNOTATED_BIBLIOGRAPHY_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 11 January 2017</p><ul class="first-line-outdent"><li><div class="bk_ref" id="Nifedipine.R1">Zimmerman HJ. Calcium channel blockers. Drugs used in cardiovascular disease. In, Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999, pp. 646-7.<div><i>(Expert review of hepatotoxicity published in 1999; among calcium channel blockers, diltiazem, nifedipine, bepridil and verapamil have been incriminated in instances of hepatic injury).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R2">De Marzio DH, Navarro VJ. Calcium channel blockers. Hepatotoxicity of cardiovascular and antidiabetic drugs. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013, pp. 524.<div><i>(Review of hepatotoxicity of calcium channel blockers mentions that diliazem, nefidipine and verapamil have been implicated in causing cholestatic liver injury in a small number of patients).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R3">Michel T, Hoffman BB. Calcium channel antagonists. Treatment of myocardial ischemia. In, Brunton LL, Chabner BA, Knollman BC, eds. Goodman &#x00026; Gilman&#x02019;s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011, pp. 755-60.<div><i>(Textbook of pharmacology and therapeutics).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R4">Rotmensch HH, Roth A, Liron M, Rubinstein A, Gefel A, Livni E. Lymphocyte sensitization in nifedipine-induced hepatitis. Br Med J 1980; 281; 976-7.  [<a href="/pmc/articles/PMC1714362/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1714362</span></a>] [<a href="/pubmed/7000285" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7000285</span></a>]<div><i>(69 year old man developed fever and jaundice 10 days after starting nifedipine [bilirubin 3.0 mg/dL, AST 56 U/L, Alk P 420 U/L, ESR 95 mm/hr], with rapid resolution and recurrence of fever and Alk P elevations after rechallenge with a single dose).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R5">Davidson AR. Lymphocyte sensitization to nifedipine-induced hepatitis. Br Med J 1980; 281: 1354.  [<a href="/pmc/articles/PMC1714796/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1714796</span></a>] [<a href="/pubmed/7437797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7437797</span></a>]<div><i>(Letter in response to Rotmensch [1980] with a similar case: 59 year old man developed fatigue 2 weeks after starting nifedipine [bilirubin 3.0 mg/dL, ALT 49 U/L, Alk P 1.5 times ULN], resolving rapidly upon stopping).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R6">Abramson M, Littlejohn GO. Hepatic reactions to nifedipine. Med J Aust 1985; 142: 47-8.  [<a href="/pubmed/3965874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3965874</span></a>]<div><i>(Two cases: 65 year old man developed jaundice 6 weeks after starting nifedipine [bilirubin 1.8 mg/dL, ALT 1220 U/L, Alk P 1094 U/L], resolving within 1 month and later tolerating verapamil; 72 year old man developed fever and arthralgias 6 weeks after starting verapamil [bilirubin normal; ALT 100 U.L, Alk P 457 U/L], resolving in a few weeks).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R7">Welch HG, Lazar B, Gresser J, McMahon BJ. Nifedipine-induced hepatitis. Alaska Med 1986; 28:11-2.  [<a href="/pubmed/3717520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3717520</span></a>]<div><i>(50 year old woman with myocardial ischemia developed AST elevations [31 rising to 361 U/L] within 4 days of starting nefidipine, with no change in bilirubin [1.0 mg/dL] and rapid resolution when it was stopped).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R8">Kiire CF, Rutherford D. Nifedipine-associated jaundice: a second case. East Afr Med J 1986; 63: 560-1.  [<a href="/pubmed/3792245" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3792245</span></a>]<div><i>(75 year old man developed jaundice and abdominal pain 2 weeks after starting nifedipine [bilirubin 3.5 mg/dL, AST 53 U/L, Alk P 139 U/L], resolving within 2 months of stopping).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R9">Richter WO, Schwandt P. Serious side effects of nifedipine. Arch Intern Med 1987; 147: 1852.  [<a href="/pubmed/3662717" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3662717</span></a>]<div><i>(69 year old woman developed marked Alk P elevations [943 U/L] with normal bilirubin [1.5 mg/dL], with no change after stopping prazosin and allopurinol, but prompt decrease after stopping nifedipine and recurrence on inadvertent rechallenge [Alk P 529 U/L]).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R10">Shaw DR, Misan GM, Johnson RD. Nifedipine hepatitis. Aust N Z J Med 1987; 17: 447-8.  [<a href="/pubmed/3435325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3435325</span></a>]<div><i>(80 year old woman developed nausea and abdominal pain 4 days after starting nifedipine and having an episode of shock [bilirubin 2.0 mg/dL, AST 1065 U/L, LDH 1190 U/L, Alk P 352 U/L], resolving within 8 weeks).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R11">Biour M, Grange JD, Barbare JC, et al. [Hepatic involvement due to nifedipine. Description of a case and review of the literature] Therapie 1987; 42: 301-3 [French].  [<a href="/pubmed/3660324" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3660324</span></a>]<div><i>(60 year old man developed jaundice 10 days after starting nifedipine [bilirubin 16.1 mg/dL, ALT 36 times ULN, Alk P 2.3 times ULN], resolving within one month of stopping).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R12">Babany G, Uzzan F, Larrey D, et al. Alcohol-like liver lesions induced by nifedipine. J Hepatol 1989; 9: 252-5.  [<a href="/pubmed/2809167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2809167</span></a>]<div><i>(78 year old woman taking nifedipine developed mild elevations of Alk P [1.5 times ULN] and GGT [5.3 times ULN] and underwent liver biopsy that showed steatohepatitis and Mallory bodies, and had ascites 6 months later despite normal enzymes; repeat biopsy showed fibrosis and fat without Mallory bodies; no follow up after stopping nefidine was given).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R13">Sawaya GF, Robertson PA. Hepatotoxicity with the administration of nifedipine for treatment of preterm labor. Am J Obstet Gynecol 1992; 167: 512-3.  [<a href="/pubmed/1497061" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1497061</span></a>]<div><i>(25 year old pregnant woman developed early uterine contractions and was treated with terbutaline and nifedipine whereupon ALT rose to as high as 845 U/L with no symptoms or jaundice, falling to normal 2 weeks after delivery and stopping nifedipine).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R14">Basile C, Mascia E. Dihydropyridine calcium channel blockers: a rare and reversible cause of hepatotoxicity with cholestasis in a CAPD patient. Nephrol Dial Transplant 1999; 14: 2776-7.  [<a href="/pubmed/10534534" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10534534</span></a>]<div><i>(76 year old man developed jaundice 3 years after starting nifedipine [bilirubin 6.2 mg/dL, ALT 79 U/L, Alk P 955 U/L], resolving within 1 month of stopping and recurring within 6 weeks of starting amlodipine [bilirubin 6.3 mg/dL, ALT 74 U/L, Alk P 398 U/L] resolving in 3 weeks: Case 1).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R15">Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366-72.  [<a href="/pubmed/10972368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10972368</span></a>]<div><i>(Randomized clinical trial of nifedipine versus diuretics for an average of 3 years in 6321 patients reported similar outcomes and no differences in adverse events; liver toxicity not mentioned).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R16">Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug-induced liver injury in the United States. Liver Transpl 2004; 10: 1018-23.  [<a href="/pubmed/15390328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15390328</span></a>]<div><i>(Among ~50,000 liver transplants reported to UNOS between 1990 and 2002, 270 [0.5%] were done for drug induced acute liver failure, but none were attributed to calcium channel blockers).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R17">Bj&#x000f6;rnsson E, Jerlstad P, Bergqvist A, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 2005; 40: 1095-101.  [<a href="/pubmed/16165719" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16165719</span></a>]<div><i> (Summary of 25 years of adverse drug reaction reporting in Sweden identified 103 cases of drug induced acute liver failure; only one case was possibly linked to a calcium channel blocker: felodipine).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R18">Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-34.  [<a href="/pmc/articles/PMC3654244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3654244</span></a>] [<a href="/pubmed/18955056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18955056</span></a>]<div><i>(Among 300 cases of drug induced liver disease in the US collected from 2004 to 2008, calcium channel blockers were implicated as a sole agent in 2 cases [1 amlodipine, 1 verapamil] and as one of several agents in 2 cases [both amlodipine]).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R19">Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010; 52: 2065-76.  [<a href="/pmc/articles/PMC3992250/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3992250</span></a>] [<a href="/pubmed/20949552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20949552</span></a>]<div><i>(Among 1198 patients with acute liver failure enrolled in a US prospective study between 1998 and 2007, 133 were attributed to drug induced liver injury, but none were linked to calcium channel blockers). </i></div></div></li><li><div class="bk_ref" id="Nifedipine.R20"><div><i>Bj&#x000f6;rnsson ES, Bergmann OM, Bj&#x000f6;rnsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013; 114: 1419-25. <a href="https://www.ncbi.nlm.nih.gov/pubmed/23419359" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Pub</a><a href="https://www.ncbi.nlm.nih.gov/pubmed/23419359" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Med Citation</a> (In a population based study of drug induced liver injury from Iceland, 96 cases were identified over a 2 year period, but no cases were attributed to calcium channel blockers).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R21">Hern&#x000e1;ndez N, Bessone F, S&#x000e1;nchez A, di Pace M, Brahm J, Zapata R, A Chirino R, et al. Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports. Ann Hepatol 2014; 13: 231-9.  [<a href="/pubmed/24552865" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24552865</span></a>]<div><i> (Systematic review of literature of drug induced liver injury in Latin American countries published from 1996 to 2012 identified 176 cases; one case was attributed to verapamil, but none were linked to diltiazem or other calcium channel blockers).</i></div></div></li><li><div class="bk_ref" id="Nifedipine.R22">Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al.; United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology 2015; 148: 1340-52.e7.  [<a href="/pmc/articles/PMC4446235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4446235</span></a>] [<a href="/pubmed/25754159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25754159</span></a>]<div><i>(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, 39 [4%] were due to antihypertensive agents including 4 due to calcium channel blockers [amlodipine in 1 and verapamil in 3 instances], but none to diltiazem).</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK548324</span><span class="label">PMID: <a href="/pubmed/31643646" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31643646</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Nicotine/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Nilotinib/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK548324&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK548324/?report=reader">PubReader</a></li><li><a href="/books/NBK548324/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK548324" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK548324" style="display:none" title="Cite this Page"><div class="bk_tt">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.  Nifedipine. [Updated 2017 Jan 11].<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK548324/pdf/Bookshelf_NBK548324.pdf">PDF version of this page</a> (114K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Bulk Download</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://ftp.ncbi.nlm.nih.gov/pub/litarch/29/31/" ref="pagearea=source-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bulk download LiverTox data from FTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Overviews</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/intro/">Introduction</a></li><li><a href="/books/n/livertox/Causality/">Causality</a></li><li><a href="/books/n/livertox/ClinicalCourse/">Clinical Course</a></li><li><a href="/books/n/livertox/ClinicalOutcome/">Clinical Outcomes</a></li><li><a href="/books/n/livertox/ImmuneFeatures/">Immune Features</a></li><li><a href="/books/n/livertox/DrugCategory/">Likelihood Scale</a></li><li><a href="/books/n/livertox/Phenotypes_intro/">Phenotypes</a></li><li><a href="/books/n/livertox/Severity/">Severity Grading</a></li><li><a href="/books/n/livertox/CaseReport/">Writing a Case Report</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Support Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/">LiverTox Homepage</a></li><li><a href="/books/n/livertox/aboutus/">About LiverTox</a></li><li><a href="/books/n/livertox/editorsandreviewers/">Editors and Review Committee</a></li><li><a href="/books/n/livertox/alert/">Meetings and News</a></li><li><a href="/books/n/livertox/abbreviation/">Abbreviations Used</a></li><li><a href="/books/n/livertox/glossary/">Glossary</a></li><li><a href="/books/n/livertox/resource/">Information Resources</a></li><li><a href="/books/n/livertox/disclaimer/">User/Medical Advice Disclaimer</a></li><li><a href="/books/n/livertox/Contactus/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>OTHER REFERENCE LINKS</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;pubmedfilters=true&amp;term=nifedipine/AE+AND+Human%5BMH%5D+AND+(drug-induced+liver+injury+OR+jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI)+AND+(%222000/1/1%22%5BEDat%5D%3A%222999/12/31%22%5BEDat%5D)" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Recent References on Nifedipine: from PubMed.gov</a></li><li><a href="https://clinicaltrials.gov/ct2/results?term=nifedipine" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Trials on Nifedipine: from ClinicalTrials.gov</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4863292" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcsubstance&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pcsubstance&amp;IdsFromResult=4863292" ref="log$=recordlinks">PubChem Substance</a><div class="brieflinkpop offscreen_noflow">Related PubChem Substances</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4863292" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643683" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Verapamil</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Verapamil<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643900" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Amlodipine</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Amlodipine<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31644064" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Nicardipine</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Nicardipine<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643892" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Calcium Channel Blockers</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Calcium Channel Blockers<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643234" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diltiazem</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diltiazem<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31643646" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31643646" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="&#10;                        HTOn&#10;                    "><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-03-08T15:41:40-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@9.2&amp;Host=portal105&amp;ncbi_phid=CE8CF28B0466CA810000000006FB021A&amp;ncbi_session=CE8CF28B0468C021_1787SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK548324%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK548324&amp;ncbi_domain=livertox&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK548324/&amp;ncbi_pagename=Nifedipine - LiverTox - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CF28B0468C021_1787SID /projects/books/PBooks@9.2 portal105 v4.1.r621975 Fri, Dec 18 2020 02:56:50 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>